Purpose
Guide for parents and caregivers to ensure their child is up-to-date on recommended childhood vaccines.
Childhood Immunization Schedule by Recommendation Group
Immunizations Recommended for All Children
| Vaccine and other immunizing agents | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 7 mos | 8 mos | 12 mos | 15 mos | 18 mos | 19 mos | 20-23 mos | 2-3 yrs | 4-6 yrs | 7 yrs | 8 yrs | 9 yrs | 10 yrs | 11 yrs | 12 yrs | 13 yrs | 14 yrs | 15 yrs | 16 yrs | 17 yrs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diphtheria, tetanus, acellular pertussis (DTaP < 7 yrs) |
1st dose
|
2nd dose
|
3rd dose
|
4th dose
|
5th dose
|
||||||||||||||||||||
| Tetanus, diphtheria, acellular pertussis (Tdap ≥ 7 yrs) |
1st dose
|
||||||||||||||||||||||||
| Haemophilus influenzae type b (Hib) |
1st dose
|
2nd dose
|
3rd dose
|
3rd/4th dose
|
|||||||||||||||||||||
| Pneumococcal conjugate (PCV15, PCV20) |
1st dose
|
2nd dose
|
3rd dose
|
4th dose
|
|||||||||||||||||||||
| Inactivated poliovirus (IPV < 18 yrs) |
1st dose
|
2nd dose
|
3rd dose
|
4th dose
|
|||||||||||||||||||||
| Measles, mumps, rubella (MMR) |
1st dose
|
2nd dose
|
|||||||||||||||||||||||
| Varicella (VAR) |
1st dose
|
2nd dose
|
|||||||||||||||||||||||
| Human papillomavirus (HPV) |
1st dose
|
||||||||||||||||||||||||
Yellow lines = Some children should get this dose of vaccine at this age depending on their dose series
Immunizations recommended for Certain High-Risk Groups or Populations
| Vaccine and other immunizing agents | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 7 mos | 8 mos | 12 mos | 15 mos | 18 mos | 19 mos | 20-23 mos | 2-3 yrs | 4-6 yrs | 7 yrs | 8 yrs | 9 yrs | 10 yrs | 11 yrs | 12 yrs | 13 yrs | 14 yrs | 15 yrs | 16 yrs | 17 yrs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Respiratory syncytial virus (RSV-mAb)1 |
1 dose
|
||||||||||||||||||||||||
| Respiratory syncytial virus (RSV-mAb)2 |
1 dose
|
2nd dose
|
|||||||||||||||||||||||
| Hepatitis B (HepB)3 |
1st dose
|
2nd dose
|
3rd dose
|
||||||||||||||||||||||
| Dengue4 |
3 dose series
|
||||||||||||||||||||||||
| Meningococcal ACWY5 |
2, 3, or 4 doses series
|
||||||||||||||||||||||||
| Meningococcal B6 |
1 dose
|
||||||||||||||||||||||||
| Hepatitis A (HepA)7 |
1 dose
|
||||||||||||||||||||||||
1 All children whose mother did not have the vaccine should get one dose.
2 High-risk children, such as those with chronic lung disease, should receive a second dose at ages 8 to 19 months.
3 Vaccination recommended for infants born to women who tested positive for the hepatitis B virus or whose status is unknown.
4 Recommended ONLY if living in areas with endemic dengue AND with a laboratory confirmation of previous dengue infection.
5 For high-risk groups (e.g., those with anatomic or functional asplenia or HIV infection), those traveling to countries with hyperendemic or epidemic meningococcal disease, and first-year college students living in residential housing, vaccination is recommended.
6 Recommended for high-risk groups, e.g., with anatomic or functional asplenia, and during outbreaks.
7 Vaccination recommended for international travel to areas with high or intermediate hepatitis A endemicity.
2 High-risk children, such as those with chronic lung disease, should receive a second dose at ages 8 to 19 months.
3 Vaccination recommended for infants born to women who tested positive for the hepatitis B virus or whose status is unknown.
4 Recommended ONLY if living in areas with endemic dengue AND with a laboratory confirmation of previous dengue infection.
5 For high-risk groups (e.g., those with anatomic or functional asplenia or HIV infection), those traveling to countries with hyperendemic or epidemic meningococcal disease, and first-year college students living in residential housing, vaccination is recommended.
6 Recommended for high-risk groups, e.g., with anatomic or functional asplenia, and during outbreaks.
7 Vaccination recommended for international travel to areas with high or intermediate hepatitis A endemicity.
Immunizations Based on Shared Clinical Decision-Making
| Vaccine and other immunizing agents | Birth | 1 mo | 2 mos | 4 mos | 6 mos | 7 mos | 8 mos | 12 mos | 15 mos | 18 mos | 19 mos | 20-23 mos | 2-3 yrs | 4-6 yrs | 7 yrs | 8 yrs | 9 yrs | 10 yrs | 11 yrs | 12 yrs | 13 yrs | 14 yrs | 15 yrs | 16 yrs | 17 yrs |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rotavirus (RV): RV1 (2-dose series), RV5 (3-dose series) |
1st dose
|
2nd dose
|
3rd dose
|
||||||||||||||||||||||
| COVID-19 (1vCOV-mRNA, 1vCOV-aPS) |
2 doses first year, then 1 dose annually
|
1 dose annually
|
|||||||||||||||||||||||
| Influenza (IIV3, ccIIV3) |
2 doses first year, then 1 dose annually
|
1 dose annually
|
|||||||||||||||||||||||
| Influenza (LAIV3) |
2 doses first year, then 1 dose annually
|
1 dose annually
|
|||||||||||||||||||||||
| Hepatitis A (HepA) |
2-dose series
|
||||||||||||||||||||||||
| Hepatitis B (HepB)* |
1st dose
|
2nd dose
|
3rd dose
|
||||||||||||||||||||||
| Meningococcal ACWY |
1st dose
|
2nd dose
|
|||||||||||||||||||||||
| Meningococcal B |
2 or 3 doses
|
||||||||||||||||||||||||
Blue lines = Some children should get this dose of vaccine at this age depending on their dose series
* For parents deciding whether to vaccinate for HepB in infants born to women who tested negative for the hepatitis B virus, it is suggested that the initial dose is administered no earlier than 2 months of age.
What diseases do these vaccines protect against?
| Vaccine-Preventable Disease | Disease Complications |
|---|---|
| Diphtheria Illness caused by a toxin produced by bacteria that infects the nose, throat, and sometimes skin. |
Swelling of the heart muscle, heart failure, coma, paralysis, death |
| Tetanus (Lockjaw) Bacterial infection of brain and nerves caused by spores found in soil and dust everywhere; spores enter the body through wounds or broken skin |
Seizures, broken bones, difficulty breathing, death |
| Pertussis (Whooping Cough) Contagious bacterial infection of the lungs and airway; spread through air and direct contact |
Infection of the lungs (pneumonia), death; especially dangerous for babies |
| Hib (Haemophilus influenzae type b) Contagious bacterial infection of the lungs, brain and spinal cord, or bloodstream; spread through air and direct contact |
Depends on the part of the body infected, but can include brain damage, hearing loss, loss of arm or leg, death |
| Pneumococcal Bacterial infections of ears, sinuses, lungs, or bloodstream; spread through direct contact with respiratory droplets like saliva or mucus |
Depends on the part of the body infected, but can include infection of the lungs (pneumonia), blood poisoning, infection of the lining of the brain and spinal cord, death |
| Polio Contagious viral infection of nerves and brain; spread through the mouth from stool on contaminated hands, food or liquid, and by air and direct contact |
Paralysis, death |
| Measles (Rubeola) Contagious viral infection that causes high fever, cough, red eyes, runny nose, and rash; spread through air and direct contact |
Brain swelling, infection of the lungs (pneumonia), death |
| Mumps Contagious viral infection that causes fever, tiredness, swollen cheeks, and tender swollen jaw; spread through air and direct contact |
Brain swelling, painful and swollen testicles or ovaries, deafness, death |
| Rubella (German Measles) Contagious viral infection that causes low-grade fever, sore throat, and rash; spread through air and direct contact |
Very dangerous in pregnant women; can cause miscarriage or stillbirth, premature delivery, severe birth defects |
| Chickenpox (Varicella) Contagious viral infection that causes fever, headache, and an itchy, blistering rash; spread through air and direct contact |
Infected sores, brain swelling, infection of the lungs (pneumonia), death |
| HPV (Human papillomavirus) Contagious viral infection spread by close skin-to-skin touching, including during sex |
Genital warts and many types of cancers later in life, including cancers of the cervix, vagina, penis, anus, and throat |
| RSV (Respiratory syncytial virus) Contagious viral infection of the nose, throat, and sometimes lungs; spread through air and direct contact |
Infection of the lungs (pneumonia) and small airways of the lungs; especially dangerous for infants and young children |
| Hepatitis B Contagious viral infection of the liver; spread through contact with infected body fluids such as blood or semen |
Chronic liver infection, liver failure, liver cancer, death |
| Dengue Viral infection spread by bite from infected mosquito; causes, fever, headache, pain behind the eyes, rash, joint pain, body ache, nausea, loss of appetite, feeling tired, abdominal pain |
Severe bleeding, seizures, shock, damage to the liver, heart, and lungs, death |
| Mpox Contagious viral infection spread through close, often skin-to-skin contact, including sex; causes a painful rash, fever, headache, tiredness, cough, runny nose, sore throat, swollen lymph nodes |
Infected sores, brain swelling, infection of the lungs (pneumonia), eye infection, blindness, death |
| Meningococcal Contagious bacterial infection of the lining of the brain and spinal cord or the bloodstream; spread through air and direct contact |
Loss of arm or leg, deafness, seizures, death |
| Rotavirus Contagious viral infection of the gut; spread through the mouth from hands and food contaminated with stool |
Severe diarrhea, dehydration, death |
| COVID-19 Contagious viral infection of the nose, throat, or lungs; may feel like a cold or flu. Spread through air and direct contact |
Infection of the lungs (pneumonia); blood clots; liver, heart or kidney damage; long COVID; death |
| Influenza (Flu) Contagious viral infection of the nose, throat, and sometimes lungs; spread through air and direct contact |
Infection of the lungs (pneumonia), sinus and ear infections, worsening of underlying heart or lung conditions, death |
| Hepatitis A Contagious viral infection of the liver; spread by contaminated food or drink or close contact with an infected person |
Liver failure, death |
